Trial Profile
FOLFIRINOX or Gemcitabine plus nab-Paclitaxel in metastatic or locally inoperable pancreatic cancer – a single center experience
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Apr 2019
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 07 Oct 2015 New trial record